Mr_Anderson007
$KOD $SLS That’s right…did some back testing on Kodiak Sciences and they reached a valuation almost 4x greater than Sellas’s current valuation PRIOR TO THEIR PHASE 3 in the past.
I’m not talking about Kodiak’s recent drugs. Kodiak reached almost $8.5 billion on older drugs (not their latest asset) that ended up FAILING!
Meanwhile here Sellas is at a $2 billion and change valuation for not one but 2 assets demonstrating category leading efficacy and safety and massive platform potential.
Thats right…min. $33 per share not a nano fing penny less BEFORE REGAL PHASE 3 FINAL ANALYSIS.
Blue sky potential after.
SLS 009 by itself is easily worth more than 2x or DOUBLE the current price.
1
11
